T44.5

Non-Billable

Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

T44.5 should not be used for reimbursement purposes as there are multiple sub-diagnoses that fall under this code. Please refer to the sub-diagnoses below.

Related Diagnoses

  • T44.5XPoisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
    • T44.5X1Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)
      • T44.5X1APoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
      • T44.5X1DPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
      • T44.5X1SPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela
    • T44.5X2Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm
      • T44.5X2APoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
      • T44.5X2DPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter
      • T44.5X2SPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela
    • T44.5X3Poisoning by predominantly beta-adrenoreceptor agonists, assault
      • T44.5X3APoisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter
      • T44.5X3DPoisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter
      • T44.5X3SPoisoning by predominantly beta-adrenoreceptor agonists, assault, sequela
    • T44.5X4Poisoning by predominantly beta-adrenoreceptor agonists, undetermined
      • T44.5X4APoisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter
      • T44.5X4DPoisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter
      • T44.5X4SPoisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela
    • T44.5X5Adverse effect of predominantly beta-adrenoreceptor agonists
      • T44.5X5AAdverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
      • T44.5X5DAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
      • T44.5X5SAdverse effect of predominantly beta-adrenoreceptor agonists, sequela
    • T44.5X6Underdosing of predominantly beta-adrenoreceptor agonists
      • T44.5X6AUnderdosing of predominantly beta-adrenoreceptor agonists, initial encounter
      • T44.5X6DUnderdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter
      • T44.5X6SUnderdosing of predominantly beta-adrenoreceptor agonists, sequela
AI Search
Analyze diagnoses and doctors notes